The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma

The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a prevalent malignant cancer worldwide, characterized by high morbidity and mortality rates. Alpha-fetoprotein (AFP) is a glycoprotein synthesized by the liver and yolk sac during fetal development. However, the serum levels of AFP exhibit a significant correlation...

Full description

Bibliographic Details
Main Authors:	Yan Lu, Bo Lin, Mengsen Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Oncology
Subjects:	hepatocellular carcinoma AFP tumor microenvironment immune escape liver cancer stem cells immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1363695/full

Similar Items

Tumor−associated macrophage polarization in the inflammatory tumor microenvironment
by: Zijuan Zou, et al.
Published: (2023-02-01)

Alpha-Fetoprotein in Predicting Survival of Patients with Ruptured Hepatocellular Carcinoma after Resection
by: Wong Hoi She, et al.
Published: (2022-05-01)

Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
by: Qiuyue Zhang, et al.
Published: (2023-06-01)

Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma
by: Li Z, et al.
Published: (2023-11-01)

Exosomes as mediators of tumor immune escape and immunotherapy in hepatocellular carcinoma
by: Ming-Cheng Guan, et al.
Published: (2022-09-01)

Alpha fetoprotein promotes polarization of macrophages towards M2-like phenotype and inhibits macrophages to phagocytize hepatoma cells
by: Minni Zhang, et al.
Published: (2023-02-01)

Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma
by: Kelley G. Núñez, et al.
Published: (2021-09-01)

The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network
by: Camilla Volponi, et al.
Published: (2022-12-01)

Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options
by: Zuzanna Sas, et al.
Published: (2022-03-01)

Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy
by: Feng H, et al.
Published: (2022-10-01)

AFP-Inhibiting Fragments for Drug Delivery: The Promise and Challenges of Targeting Therapeutics to Cancers
by: Bo Lin, et al.
Published: (2021-04-01)

Differences Between Alpha-Fetoprotein (AFP) and Prothrombin Induced by Vitamin K Absence or antagonist II (PIVKA-II) Values as Early Detection Method for Hepatocellular Carcinoma (HCC) and Cirrhosis
by: Bayu Eka Nugraha, et al.
Published: (2020-07-01)

Evaluation of the Alpha-Fetoprotein Model for Predicting Recurrence and Survival in Patients With Hepatitis B Virus (HBV)–Related Cirrhosis Who Received Liver Transplantation for Hepatocellular Carcinoma
by: Ao Ren, et al.
Published: (2020-08-01)

Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma
by: Zhuomao Mo, et al.
Published: (2021-02-01)

Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level
by: Madison Force, et al.
Published: (2022-04-01)

IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
by: Junnv Xu, et al.
Published: (2021-12-01)

NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma
by: Yu-Mei Ning, et al.
Published: (2022-08-01)

A stratification model of hepatocellular carcinoma based on expression profiles of cells in the tumor microenvironment
by: Chunting Zeng, et al.
Published: (2022-06-01)

A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma
by: Zhan Yang, et al.
Published: (2022-12-01)

SERUM AFP (ALPHA FETO PROTEIN) LEVELS PROFILE OF HEPATOCELLULAR CARCINOMA PATIENTS IN DR. SOETOMO GENERAL ACADEMIC HOSPITAL, SURABAYA, INDONESIA
by: Dyeneka Rustanti Indreswara Putri, et al.
Published: (2022-01-01)

KIF5A upregulation in hepatocellular carcinoma: A novel prognostic biomarker associated with unique tumor microenvironment status
by: Qi Liu, et al.
Published: (2023-01-01)

The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients
by: Jingrui Wang, et al.
Published: (2023-03-01)

A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma
by: Zaoqu Liu, et al.
Published: (2021-01-01)

Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma
by: Tanghua Li, et al.
Published: (2023-06-01)

Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma
by: Diamantis I. Tsilimigras, et al.
Published: (2021-02-01)

Development And Validation Of A Simple Model For Detection Of Early Hepatocellular Carcinoma In A Liver Cirrhosis Cohort
by: Li T, et al.
Published: (2019-11-01)

Editorial: The tumor microenvironment and malignant properties in primary liver cancer
by: Chen Qu
Published: (2023-08-01)

Reappraisal of the roles of alpha-fetoprotein in hepatocellular carcinoma surveillance using large-scale nationwide database and hospital-based information
by: Shu-Hsien Lin, et al.
Published: (2022-10-01)

Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study
by: Linbin Lu, et al.
Published: (2022-05-01)

Feasibility of hepatocellular carcinoma treatment based on the tumor microenvironment
by: Haiqiang Wang, et al.
Published: (2022-09-01)

The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy
by: Ming-Chao Tsai, et al.
Published: (2021-06-01)

Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
by: Chen Chen, et al.
Published: (2023-02-01)

Correlation of Serum Alpha-Fetoprotein (AFP) Levels with the size of Hepatocellular carcinoma on Triphasic CT scan: A study in patients with the heterotrophic viral infection
by: Javeria Khan, et al.
Published: (2022-06-01)

Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment
by: Jingjuan Zhu, et al.
Published: (2023-03-01)

Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and <it>pgk</it> promoter: an <it>in vitro</it> and <it>in vivo</it> study
by: Li Wei, et al.
Published: (2012-11-01)

Macrophages and hepatocellular carcinoma
by: Zhiqiang Tian, et al.
Published: (2019-09-01)

Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages
by: Jingyi Zhou, et al.
Published: (2021-02-01)

An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment
by: Huang-Zhen Xu, et al.
Published: (2023-09-01)

Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma
by: Ali OM, et al.
Published: (2020-05-01)

Deep dissection of stemness-related hierarchies in hepatocellular carcinoma
by: Rui Liang, et al.
Published: (2023-09-01)